The interplay between monosodium glutamate (MSG) consumption and metabolic disorders.

Kayode OT, Bello JA, Oguntola JA, Kayode AAA, Olukoya DK

DOI: 10.1016/j.heliyon.2023.e19675
Published: 2023 Sep
Container: Heliyon
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.heliyon.2023.e19675,
  title = {The interplay between monosodium glutamate (MSG) consumption and metabolic disorders.},
  author = {Kayode OT and Bello JA and Oguntola JA and Kayode AAA and Olukoya DK},
  year = {2023},
  journal = {Heliyon},
  doi = {10.1016/j.heliyon.2023.e19675},
  url = {https://doi.org/10.1016/j.heliyon.2023.e19675}
}

RIS

TY  - JOUR
TI  - The interplay between monosodium glutamate (MSG) consumption and metabolic disorders.
AU  - Kayode OT
AU  - Bello JA
AU  - Oguntola JA
AU  - Kayode AAA
AU  - Olukoya DK
PY  - 2023
JO  - Heliyon
DO  - 10.1016/j.heliyon.2023.e19675
UR  - https://doi.org/10.1016/j.heliyon.2023.e19675
ER  -

APA

OT, K., JA, B., JA, O., AAA, K., & DK, O. (2023). The interplay between monosodium glutamate (MSG) consumption and metabolic disorders.. Heliyon. https://doi.org/10.1016/j.heliyon.2023.e19675

Source records

pubmed · retrieved 2026-09-25T14:44:50.517Z